Biomedicina Traslacional

  • ISSN: 2172-0479
  • Índice h de la revista: 16
  • Puntuación de cita de revista: 5.91
  • Factor de impacto de la revista: 3.66
Indexado en
  • Abrir puerta J
  • Genamics JournalSeek
  • DiarioTOCs
  • InvestigaciónBiblia
  • El Factor de Impacto Global (GIF)
  • Infraestructura Nacional de Conocimiento de China (CNKI)
  • CiteFactor
  • cimago
  • Biblioteca de revistas electrónicas
  • Directorio de indexación de revistas de investigación (DRJI)
  • OCLC-WorldCat
  • Convocatoria de búsqueda
  • Publón
  • miar
  • Comisión de Becas Universitarias
  • Fundación de Ginebra para la Educación e Investigación Médica
  • Google Académico
  • SHERPA ROMEO
  • Laboratorios secretos de motores de búsqueda
  • Puerta de la investigación
Comparte esta página

Abstracto

Orthopaedic Research in United States during the Covid-19 Era

William Stetson

The quick and broad use of telemedicine across disciplines, including orthopaedics, was prompted by the coronavirus pandemic. In a short amount of time, newly approved telehealth practises have gone from being an experiment to the standard as a result of a series of circumstances, starting with payers, moving on to providers adoption, and then reciprocated by patients. The COVID-19 era is not the end of telemedicine, according to orthopaedic surgeons, but there are still a lot of long-term adjustments that payers, providers, and patients need to make if tele health is to continue. The purpose of this study is to describe the chain of events that led to the widespread adoption of telemedicine in orthopaedic clinics around the world, to show how irreversible its adoption is, and to spark discussion about next measures that may be taken to maintain its advantages.